Hypovitaminosis D is associated with depression and anxiety in schizophrenia: results from the national FACE-SZ cohort. Running title: hypovitaminosis D, depression and anxiety in schizophrenia

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological treatment of adult bipolar disorder

  2019cited by this paper
• The effect of vitamin D supplementation on thyroid autoantibody levels in the treatment of autoimmune thyroiditis: a systematic review and a meta-analysis

  2018cited by this paper
• Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set

  2018cited by this paper
• Mediation Analyses of Insight, Quality of Life, Depression, and Suicidality: Results From the FACE-SZ Cohort.

  2018cited by this paper
• Association between vitamin D status and metabolic syndrome risk factors.

  2018cited by this paper
• Correlates of Vitamin D in Psychotic Disorders: A comprehensive Systematic Review Psychiatry Research

  2018cited by this paper
• Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments.

  2018cited by this paper
• Metabolic Syndrome and Vitamin D Levels in Patients with Obstructive Sleep Apnea Syndrome

  2018cited by this paper
• Association Between Vitamin D Insufficiency and Metabolic Syndrome in Patients With Psychotic Disorders

  2018cited by this paper
• Hypovitaminosis D is associated with negative symptoms, suicide risk, agoraphobia, impaired functional remission, and antidepressant consumption in schizophrenia

  2018cited by this paper
• Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort.

  2018cited by this paper
• Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis.

  2018cited by this paper
• Associations of vitamin D status with markers of metabolic health: A community-based study in Shanghai, China.

  2018cited by this paper
• Efficacy of adding nutritional supplements in unipolar depression: A systematic review and meta-analysis.

  2017cited by this paper
• Pharmacological guidelines for schizophrenia: a systematic review and comparison of recommendations for the first episode

  2017cited by this paper
• Vitamin D Levels in Different Severity Groups of Schizophrenia

  2017cited by this paper
• 'When you are homeless, you are not thinking about your medication, but your food, shelter or heat for the night': behavioural determinants of homeless patients' adherence to prescribed medicines.

  2017cited by this paper
• Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism

  2017cited by this paper
• Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial

  2017cited by this paper
• Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.

  2017cited by this paper
• Nutritional Deficiencies and Clinical Correlates in First-Episode Psychosis: A Systematic Review and Meta-analysis

  2017cited by this paper
• Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset.

  2017cited by this paper
• The Role of Vitamin D in Thyroid Diseases

  2017cited by this paper
• Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort.

  2017cited by this paper
• Association between mental disorders, cognitive disturbances and vitamin D serum level: Current state.

  2017cited by this paper
• Vitamin D and alcohol: A review of the current literature.

  2017cited by this paper
• Prevalence of Vitamin D Deficiency in Adult Outpatients With Bipolar Disorder or Schizophrenia

  2016cited by this paper
• Low levels of vitamin D poorly responsive to daylight exposure in patients with therapy-resistant schizophrenia

  2016cited by this paper
• The California verbal learning test

  2016cited by this paper
• Validation of the Medication Adherence Rating Scale in homeless patients with schizophrenia: Results from the French Housing First experience

  2016cited by this paper
• The Relationship between Symptom Severity and Low Vitamin D Levels in Patients with Schizophrenia

  2016cited by this paper
• Recommendations for the optimal care of patients with recent‐onset psychosis in the Asia‐Pacific region

  2016cited by this paper
• Low vitamin D is associated with negative and depressive symptoms in psychotic disorders.

  2016cited by this paper
• Prevalence and determinants of vitamin D deficiency in healthy French adults: the VARIETE study

  2016cited by this paper
• Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset

  2015cited by this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation

  2015cited by this paper
• Correlates of major depressive disorder with and without comorbid alcohol use disorder nationally in the veterans health administration.

  2015cited by this paper
• NICE CG178 Psychosis and Schizophrenia in Adults: Treatment and Management – an evidence-based guideline?

  2015cited by this paper
• Serum vitamin D and hippocampal gray matter volume in schizophrenia.

  2015cited by this paper
• Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first‐episode schizophrenia

  2015cited by this paper
• Depression in patients with alcohol use disorders: Systematic review and meta-analysis of outcomes for independent and substance-induced disorders.

  2015cited by this paper
• Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset.

  2015cited by this paper
• A National Network of Schizophrenia Expert Centres: an Innovative Tool to Bridge the Research-Practice Gap

  2015cited by this paper
• High levels of vitamin D in relation to reduced risk of schizophrenia with elevated C-reactive protein.

  2015cited by this paper
• Mood disorders are associated with a more severe hypovitaminosis D than schizophrenia.

  2015influential reference
• Low vitamin D levels predict clinical features of schizophrenia.

  2014cited by this paper
• Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation

  2014cited by this paper
• Self-reported major depressive symptoms at baseline impact abstinence prognosis in smoking cessation program. A one-year prospective study.

  2013cited by this paper
• “Meta-guidelines” for the management of patients with schizophrenia

  2013cited by this paper
• [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].

  2013cited by this paper
• Evaluation of the Housing First program in patients with severe mental disorders in France: study protocol for a randomized controlled trial

  2013cited by this paper
• Vitamin D and psychosis: mini meta-analysis.

  2013cited by this paper
• Toward Meeting the Needs of Homeless People with Schizophrenia: The Validity of Quality of Life Measurement

  2013cited by this paper
• Duration of untreated bipolar disorder: missed opportunities on the long road to optimal treatment

  2013cited by this paper
• Low serum vitamin D concentrations in patients with schizophrenia.

  2012cited by this paper
• Serum 25-hydroxyvitamin D levels and the risk of depression: A systematic review and meta-analysis

  2012cited by this paper
• Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia.

  2012cited by this paper
• Prevalence of Bipolar Disorder and Schizophrenia in Houston Outreach Medicine, Education, and Social Services (HOMES) Clinic Patients: Implications for Student-Managed Clinics for Underserved Populations

  2012cited by this paper
• A French network of bipolar expert centres: a model to close the gap between evidence-based medicine and routine practice.

  2011cited by this paper
• Mood Symptoms, Cognition, and Everyday Functioning

  2011cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2010cited by this paper
• Associations between depression subtypes and substance use disorders.

  2008cited by this paper
• The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

  2008cited by this paper
• Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation

  2006influential reference
• The American Psychiatric Association

  2005cited by this paper
• [The estimation of premorbid intelligence levels in French speakers].

  2005cited by this paper
• Practice guideline for the treatment of patients with schizophrenia, second edition.

  2004cited by this paper
• Schizophrenia in homeless persons: a systematic review of the literature

  2002cited by this paper
• Adjusting for multiple testing--when and how?

  2001cited by this paper
• Echelle d'intelligence de Wechsler pour adultes

  2000cited by this paper
• Validity, reliability, and standard errors of measurement for two seven-subtest short forms of the Wechsler Adult Intelligence Scale—III.

  1999cited by this paper
• The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

  1998cited by this paper
• Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test.

  1978cited by this paper
• Validity of the Trail Making Test as an Indicator of Organic Brain Damage

  1958cited by this paper

• The efficacy of nutritional supplements for the adjunctive treatment of schizophrenia in adults: A systematic review and network meta-analysis.

  2022cites this paper
• Vitamin D and Schizophrenia: Association, Therapeutic Potential and Mechanisms

  2022influential citation
• Anxiety Disturbs Metabolome of Blood Plasma in Coronary Heart Disease Patients

  2021cites this paper
• Vitamin D and schizophrenia: 20 years on

  2021cites this paper
• Anxiety disturbs the blood plasma metabolome in acute coronary syndrome patients

  2021cites this paper
• Vitamin D in the time of the coronavirus (COVID-19) pandemic – a clinical review from a public health and public mental health perspective

  2021cites this paper
• The association between vitamin D and symptom domains in psychotic disorders: A systematic review.

  2021cites this paper
• Vitamin D and the Risks of Depression and Anxiety: An Observational Analysis and Genome-Wide Environment Interaction Study

  2021cites this paper
• Research Paper: The Relationship Between Vitamin D Levels and the Severity of Anxiety and Depression in Patients Under Methadone Maintenance Treatment

  2021cites this paper
• Vitamin D Deficiency Linked To Depression (Systematic Review: Meta Synthesis)

  2021influential citation
• Comorbid Major Depressive Disorder in Schizophrenia: A Systematic Review and Meta-Analysis.

  2020cites this paper
• Increased in-hospital mortality from COVID-19 in patients with schizophrenia

  2020cites this paper
• Correction to: Contributions of Vitamin D in the management of depressive symptoms and cardiovascular risk factors: study protocol for a randomized, double-blind, placebo-controlled clinical trial

  2019cites this paper
• Contribuições da vitamina D no tratamento de sintomas depressivos e fatores de risco cardiovascular: protocolo de estudo para um ensaio clínico randomizado, duplo-cego e controlado por placebo

  2019cites this paper
• Hypsarrhythmia and spasms resolution after Valproic acid discontinuation in an infantile spasm patient

  2019cites this paper
• The association between anxiety and depression with 25(OH)D and thyroid stimulating hormone levels

  2019cites this paper
• DNND_A_204555 39..53

  2019cites this paper
• Vitamin D status and correlates of low vitamin D in schizophrenia, other psychoses and non-psychotic depression - The Northern Finland Birth Cohort 1966 study.

  2019cites this paper
• Vitamin D Deficiency in the Gulf Cooperation Council: Exploring the Triad of Genetic Predisposition, the Gut Microbiome and the Immune System

  2019cites this paper
• Vitamin D status and correlates of low vitamin D in schizophrenia, other psychoses and non–psychotic depression – The Northern Finland Birth Cohort Submission Files Included in this PDF

  2019cites this paper